EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Role of Biomarkers in Upper Gastrointestinal Cancers

Nathalie Baudoux, Francine Aubin

Canadian Oncology Today · 2025

DOI: 10.58931/cot.2025.2133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Oncology Today, 2025. Verfasst von Nathalie Baudoux und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Upper gastrointestinal (GI) cancers include esophageal, esophagogastric junction, and stomach cancers, which together represent the second leading cause of cancer-related mortality worldwide in both sexes, with approximately 1,100,000 deaths in 2022. The disease is usually diagnosed at an advanced non-curable stage, and conventional chemotherapy treatment is associated with poor prognosis. Advances have been made in the development of new therapies, including immunotherapy and targeted therapies. Biomarker identification has expanded treatment options and guides treatment selection. This article reviews the molecular characterization of GI cancers, which has been the subject of increasing research, and biomarker-targeted agents, representing a continually evolving landscape in upper GI cancers.

Zitieren

APA

Baudoux, N., & Aubin, F. (2025). The Role of Biomarkers in Upper Gastrointestinal Cancers. Canadian Oncology Today. https://doi.org/10.58931/cot.2025.2133

Vancouver

Baudoux N, Aubin F. The Role of Biomarkers in Upper Gastrointestinal Cancers. Canadian Oncology Today. 2025. doi:10.58931/cot.2025.2133

BibTeX
@article{Baudoux2025,
  author = {Baudoux, Nathalie and Aubin, Francine},
  title = {The Role of Biomarkers in Upper Gastrointestinal Cancers},
  journal = {Canadian Oncology Today},
  year = {2025},
  doi = {10.58931/cot.2025.2133}
}
Kostenlos starten →